• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global Health

    How should Mark Zuckerberg and Priscilla Chan spend $3B to end disease?

    The Chan Zuckerberg Initiative commits $3 billion over the next decade to curing disease in the next century. Here's how global health experts hope they'll spend the money.

    By Catherine Cheney // 29 September 2016

    Facebook CEO Mark Zuckerberg and Priscilla Chan’s $3 billion commitment to cure, manage, or end all disease by the end of the century has sparked the imaginations of the global public health community.

    For now, details on the Chan Zuckerberg Initiative, which was launched in December are still limited. But its ambitions from education to global health have launched new conversations about where funds are most needed. Chan Zuckerberg Science will take a unique approach by committing significant financial resources to basic science research over the next decade.

    The commitment is noteworthy not only because of its dollar figure but “because of its focus on basic science research, rather than applied or translational research, its intent to develop tools and technology for the use of scientists everywhere, and its facilitation of interdisciplinary collaboration such as that between engineering and the life sciences,” Marc Kastner, the president of the Science Philanthropy Alliance, told Devex. “These strategies can help accelerate discoveries around the world to cure, prevent and manage disease.”

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Innovation & ICT
    • Funding
    • Worldwide
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Catherine Cheney

      Catherine Cheneycatherinecheney

      Catherine Cheney is the Senior Editor for Special Coverage at Devex. She leads the editorial vision of Devex’s news events and editorial coverage of key moments on the global development calendar. Catherine joined Devex as a reporter, focusing on technology and innovation in making progress on the Sustainable Development Goals. Prior to joining Devex, Catherine earned her bachelor’s and master’s degrees from Yale University, and worked as a web producer for POLITICO, a reporter for World Politics Review, and special projects editor at NationSwell. She has reported domestically and internationally for outlets including The Atlantic and the Washington Post. Catherine also works for the Solutions Journalism Network, a non profit organization that supports journalists and news organizations to report on responses to problems.

    Search for articles

    Related Stories

    Global healthOpinion: Diaspora scientists are supercharging Africa’s health innovation

    Opinion: Diaspora scientists are supercharging Africa’s health innovation

    Global HealthOpinion: A new panel could be our best weapon against drug resistance

    Opinion: A new panel could be our best weapon against drug resistance

    PhilanthropyBill Gates commits most of his fortune to Gates Foundation, closing 2045

    Bill Gates commits most of his fortune to Gates Foundation, closing 2045

    Global healthHow US Health and Human Services budget cuts could impact global health

    How US Health and Human Services budget cuts could impact global health

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      The UN's changing of the guard
    • 3
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 4
      Opinion: India’s bold leadership in turning the tide for TB
    • 5
      Lasting nutrition and food security needs new funding — and new systems
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement